DK1742656T3 - Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine - Google Patents

Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine

Info

Publication number
DK1742656T3
DK1742656T3 DK05733210.8T DK05733210T DK1742656T3 DK 1742656 T3 DK1742656 T3 DK 1742656T3 DK 05733210 T DK05733210 T DK 05733210T DK 1742656 T3 DK1742656 T3 DK 1742656T3
Authority
DK
Denmark
Prior art keywords
skin extract
peanut skin
hitherto unknown
adjuvant vaccine
unknown peanut
Prior art date
Application number
DK05733210.8T
Other languages
English (en)
Inventor
Larry Robert Mcdougald
Alberta Lorraine Fuller
Original Assignee
Univ Georgia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia filed Critical Univ Georgia
Application granted granted Critical
Publication of DK1742656T3 publication Critical patent/DK1742656T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seeds, Soups, And Other Foods (AREA)
DK05733210.8T 2004-03-12 2005-03-14 Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine DK1742656T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55263604P 2004-03-12 2004-03-12
PCT/US2005/008400 WO2005089262A2 (en) 2004-03-12 2005-03-14 Novel peanut skin extract as a vaccine adjuvant

Publications (1)

Publication Number Publication Date
DK1742656T3 true DK1742656T3 (da) 2010-07-19

Family

ID=34994226

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05733210.8T DK1742656T3 (da) 2004-03-12 2005-03-14 Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine

Country Status (6)

Country Link
EP (1) EP1742656B1 (da)
AT (1) ATE471155T1 (da)
CA (1) CA2559272C (da)
DE (1) DE602005021873D1 (da)
DK (1) DK1742656T3 (da)
WO (1) WO2005089262A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879342B2 (en) * 2004-03-12 2011-02-01 Univ. Of Georgia Research Foundation, Inc. Vaccine adjuvant and making and using the same
MX2010012869A (es) 2008-05-29 2010-12-14 Intervet Int Bv Vacunas contra coccidiosis.
MX2011005133A (es) 2008-11-13 2011-08-04 Intervet Int Bv Vacuna contra eimeria para pavos.

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4639372A (en) 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5279960A (en) 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
DE3752263T2 (de) 1986-08-18 1999-07-08 Btg Int Ltd Impfstoffe
US4808404A (en) 1988-01-11 1989-02-28 A. H. Robins Company, Inc. Live vaccine for coccidiosis utilizing coccidial sporozoites
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
ZA894726B (en) 1988-06-27 1990-03-28 Akzo Nv Coccidiosis vaccine
US5068104A (en) 1988-08-01 1991-11-26 A. H. Robins Company Incorporated Live vaccine for coccidiosis utilizing coccidial sporozoites
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
ZA902147B (en) 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
DE68909041T2 (de) 1989-06-21 1994-01-13 Akzo Nv Eimeria tenella-Vakzin.
ATE141328T1 (de) 1991-03-14 1996-08-15 British Tech Group Usa Rekombinante vakzine gegen coccidiose
ZA924203B (en) 1991-06-18 1993-03-31 Akzo Nv Coccidiosis poultry vaccine
EP0594743B1 (en) 1991-07-12 1999-09-22 Pfizer Inc. Continuous cell line and vaccine against avian coccidia
EP0653489B1 (en) 1993-11-12 2003-02-19 Akzo Nobel N.V. Coccidiosis poultry vaccin
NZ272945A (en) 1994-09-16 1997-12-19 Akzo Nobel Nv Eimeria t-lymphocyte stimulating protein and coding sequence, its production and use
US5554645A (en) 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
US6777005B1 (en) 1994-10-03 2004-08-17 Mars, Incorporated Foods containing a cocoa polyphenol additive
US5566064A (en) 1995-05-26 1996-10-15 Apple Computer, Inc. High efficiency supply for electroluminescent panels
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US6469053B1 (en) 1996-04-02 2002-10-22 Mars Incorporated Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
US6297273B1 (en) 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US6696485B1 (en) 1996-04-02 2004-02-24 Mars, Incorporated Procyanidin and cyclo-oxygenase modulator compositions
US6207842B1 (en) 1997-10-09 2001-03-27 Mars Incorporated Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6805883B2 (en) 1998-03-12 2004-10-19 Mars, Incorporated Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
US6156912A (en) 1999-04-09 2000-12-05 Mars, Incorporated 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en) 1999-04-15 2006-03-21 Mars Incorporated Synthetic methods for preparing procyanidin oligomers
US6476241B1 (en) 2000-09-05 2002-11-05 Mars Incorporated Synthesis of 4α-arylepicatechins
WO2004052393A1 (en) 2002-12-09 2004-06-24 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same

Also Published As

Publication number Publication date
WO2005089262A2 (en) 2005-09-29
WO2005089262A3 (en) 2006-10-12
CA2559272C (en) 2015-12-01
EP1742656A4 (en) 2007-11-14
CA2559272A1 (en) 2005-09-29
EP1742656B1 (en) 2010-06-16
DE602005021873D1 (de) 2010-07-29
EP1742656A2 (en) 2007-01-17
ATE471155T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
PH12014501836A1 (en) Novel adjuvant compositions
IN2014DN08830A (da)
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
BRPI1007721B1 (pt) composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66
BRPI0607551A2 (pt) vacinas de combinação de helicobacter e circovìrus porcino e métodos de uso
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2008148057A3 (en) Cationic lipids compositions and methods for enhancing immune responses to vaccines
GB2386072A (en) Novel vaccine
WO2006136460A8 (en) New adjuvant
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
WO2008133208A1 (ja) ペプチド免疫応答増強方法
BR112016002354A2 (pt) composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit
DE60336588D1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
MX344544B (es) Vacuna para paludismo en etapa sanguinea.
DK1742656T3 (da) Hidtil ukendt jordnøddeskindekstrakt som adjuvansvaccine
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
TN2010000338A1 (en) Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
UA104138C2 (en) Novel adjuvant compositions